This stock’s slumped 40%+ in two days! Is it the opportunity of a lifetime for ISA investors?

This growth stock’s been taking an absolute pounding in recent days. But is it now a gift horse at current prices? Royston Wild takes a look.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Sirius Minerals and Thomas Cook Group have commanded the bulk of negative headlines in recent days but spare a thought for shareholders over at PureCircle (LSE: PURE), too.

PureCircle — which claims to be “the world’s leading producer and innovator of great tasting stevia sweeteners for the global food and beverage industry” — has seen its share price clatter 41% lower since Friday’s open. The reason why? The postponement of full-year results originally slated for today due to some serious accounting errors.

Not so sweet

According to the small-cap, its auditor, PricewaterhouseCoopers has identified “a potential issue relating to the classifiation and valuation of certain inventory items,” while assessing financial statements for the fiscal year ending June 2019. A formal investigation is now under way.

PureCircle estimates that the issue could cost it up to $30m, although it commented that it’s “unable to determine whether or not the potential issue is material or whether it is limited to [fiscal 2019].” It added that while there’s no sign that the anomaly will have an impact on net debt or cash generation, the business will be approaching its lenders with a view to seeking appropriate waivers under its banking arrangements as required.

New products 

This isn’t the first time that PureCircle has spooked the market recently. Back in July it advised that sales for fiscal 2019 would fall short of expectations (at $125m) because of delayed product launches which slipped into the current financial year.

The sweetener manufacturer’s been taking steps to overhaul its product spectrum of late to concentrate on the better-tasting and higher-margin Reb M range. This improving mix has already had a marked effect on gross margins (up 2.4% during July-December, to 39.2%), though for the moment this is having a cannibalistic effect on its base business. In the first half, total sales dropped 5.2% to $50.7m.

Is it a buy?

PureCircle, then, clearly isn’t without its troubles. But there’s no doubting that the business has terrific potential as consumers increasingly switch from sugar to sweetener alternatives.

Indeed, a recent report from Mordor Intelligence suggests that the global stevia market will rise by a compound annual growth rate of 8.43% through to 2024, and will be worth a whopping $934m by the end of the period.

The battle against obesity and diabetes in the West, combined with booming population levels and rising incomes in emerging markets, look set to drive demand for zero-calorie stevia products to the stars. And through its strong pipeline and improving range of applications, PureCircle has huge potential to ride this tiger.

But does this make the business a buy right now? Not in my book. Its share price might have dropped significantly, but it still looks quite expensive on paper with a forward P/E ratio of 31.2 times. And this high rating gives it plenty of scope to keep sinking should more trouble related to its accounting practices occur, and/or extra product launch delays also transpire. I’m quite happy to sit on my hands for the time being.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »